<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-E6-14263">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2006_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-22</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Skin Bleaching Drug Products For Over-the-Counter Human Use; Proposed Rule</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2006-08-29/html/E6-14263.htm">
        <identifier type="FDsys Unique ID">D09002ee1c80ede99</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2006-08-29/pdf/E6-14263.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c80edf06</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would establish that over-the-counter (OTC) skin bleaching drug products are not generally recognized as safe and effective (GRASE) and are misbranded. FDA is also withdrawing the previous proposed rule on skin bleaching drug products for OTC human use, which was issued in the form of a tentative final monograph (TFM). FDA is issuing this proposed rule after considering new data and information on the safety of hydroquinone, the only active ingredient that had been proposed for inclusion in a monograph for these products. This proposal is part of FDA's ongoing review of OTC drug products. Further, upon issuance of a final rule, FDA intends to consider all skin bleaching drug products, whether currently marketed on a prescription or OTC basis, to be new drugs requiring an approved new drug application (NDA) for continued marketing.</abstract>
    <identifier type="FR citation">71 FR 51146</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2006-08-29/E6-14263</identifier>
    <identifier type="FR Doc No.">E6-14263</identifier>
    <identifier type="former granule identifier">fr29au06-17</identifier>
    <identifier type="Regulation ID Number">RIN 0910-AF53</identifier>
    <identifier type="billing code">4160-01-S</identifier>
    <identifier type="department code">Docket No. 1978N-0065 (formerly Docket No. 78N-0065)</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2006-08-29/E6-14263</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2006-08-29/html/E6-14263.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2006-08-29/pdf/E6-14263.pdf</url>
    </location>
    <physicalDescription>
        <extent>10 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>51146</start>
            <end>51155</end>
        </extent>
    </part>
    <identifier type="preferred citation">71 FR 51146</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 310</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  310</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0910-AF53</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0910-AF53</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Skin Bleaching Drug Products For Over-the-Counter Human Use; Proposed Rule; Federal Register Vol. 71, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>E6-14263</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <commentDate>2006-12-27</commentDate>
        <departmentDoc>Docket No. 1978N-0065 (formerly Docket No. 78N-0065)</departmentDoc>
        <rin number="0910-AF53"/>
        <billingCode>4160-01-S</billingCode>
        <frDocNumber>E6-14263</frDocNumber>
        <action>Proposed rule; withdrawal of previous proposed rule.</action>
        <summary>The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would establish that over-the-counter (OTC) skin bleaching drug products are not generally recognized as safe and effective (GRASE) and are misbranded. FDA is also withdrawing the previous proposed rule on skin bleaching drug products for OTC human use, which was issued in the form of a tentative final monograph (TFM). FDA is issuing this proposed rule after considering new data and information on the safety of hydroquinone, the only active ingredient that had been proposed for inclusion in a monograph for these products. This proposal is part of FDA's ongoing review of OTC drug products. Further, upon issuance of a final rule, FDA intends to consider all skin bleaching drug products, whether currently marketed on a prescription or OTC basis, to be new drugs requiring an approved new drug application (NDA) for continued marketing.</summary>
        <dates>Submit written or electronic comments by December 27, 2006; submit written or electronic comments on FDA's economic impact determination by December 27, 2006. The September 3, 1982, proposed rule (47 FR 39108) is withdrawn as of August 29, 2006. See section IX for the proposed effective date of any final rule that may publish based on this proposal.</dates>
        <contact>Michelle M. Jackson, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 5486, Silver Spring, MD 20993-0002, 301- 796-0923.</contact>
        <cfr title="21">
                                    
            <part number="310"/>
                                
        </cfr>
        <tocSubject1>Human drugs:</tocSubject1>
        <tocDoc>Skin bleaching drug products; over-the-counter use, </tocDoc>
        <urlRef>http://www.fda.gov/dockets/ecomments</urlRef>
        <urlRef>http://www.fda.gov/ohrms/dockets/default.htm</urlRef>
        <urlRef>http://www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee180965019" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2006-08-29/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 71, no. 167</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2006-08-29</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>337 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2006-08-29">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2006-08-29</identifier>
        <identifier type="local">P0b002ee180965019</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr29au06</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2006-08-29</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2006-08-29/pdf/FR-2006-08-29.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2006-08-29/xml/FR-2006-08-29.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>51095</start>
                <end>51420</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-22</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-06</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2006-08-29</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2006-08-29</accessId>
            <volume>71</volume>
            <issue>167</issue>
        </extension>
    </relatedItem>
</mods>
